Skip to main content
GEHC
NASDAQ Industrial Applications And Services

GE HealthCare Q2: Record Orders, Backlog, and Reaffirmed Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$67.8
Mkt Cap
$29.163B
52W Low
$58.75
52W High
$89.77
52W Position info
15% above low
Off High info
24% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

GEHC sits 15% above its 52-week low of $58.75.

Summary

GE HealthCare posted Q2 2026 results featuring record orders and backlog, 5.7% revenue growth, and reaffirmed full-year guidance, alongside a strategic review of its challenged Patient Care Solutions segment.


Key Events · Earnings and Guidance · GEHC

  • Record Orders and Backlog

    Organic orders surged 11.1% year-over-year, yielding a book-to-bill of 1.15x and lifting the backlog to $23.9 billion.

  • Revenue and Earnings Beat

    Revenue reached $5.3 billion, up 5.7% (organic growth 3.5%); diluted EPS rose 16.5% to $1.24, and Adjusted EPS increased 6.6% to $1.13.

  • Full-Year Guidance Reaffirmed

    The 2026 outlook was reaffirmed: organic revenue growth of 3-4%, Adjusted EBIT margin of 15.4-15.7%, Adjusted EPS of $4.80-$5.00, and free cash flow of approximately $1.6 billion.

  • Strategic Review of Patient Care Solutions

    Management is evaluating strategic options for the Patient Care Solutions segment, which suffered a 13.3% revenue decline and a negative segment EBIT margin.


Analysis · GEHC · Industrial Applications And Services

A standout quarter for GE HealthCare was anchored by record organic orders growth of 11.1% and a book-to-bill of 1.15x, swelling the backlog to $23.9 billion. Revenue climbed 5.7% to $5.3 billion, propelled by Pharmaceutical Diagnostics and Advanced Imaging Solutions, while persistent weakness in Patient Care Solutions triggered a strategic review. The company reaffirmed its full-year 2026 guidance, underscoring confidence in sustained demand. The quarter also benefited from tariff refunds, and the share buyback program continued with $200 million in repurchases.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GEHC was trading at $67.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $29.2B. The 52-week trading range was $58.75 to $89.77. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GEHC - Latest Insights

GEHC
Oct 28, 2026, 1:18 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $76.88
Real-time Price: $82.99 info
Change: +$6.11 (+8%) info
Market Cap: $37.509B info
GEHC
Oct 28, 2026, 6:26 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $74.90
Real-time Price: $82.99 info
Change: +$8.09 (+11%) info
Market Cap: $37.509B info
GEHC
Oct 28, 2026, 6:25 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $74.90
Real-time Price: $82.99 info
Change: +$8.09 (+11%) info
Market Cap: $37.509B info
GEHC
Oct 28, 2026, 6:20 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $71.59
Real-time Price: $82.99 info
Change: +$11.40 (+16%) info
Market Cap: $37.509B info
GEHC
Oct 05, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $65.43
Real-time Price: $82.99 info
Change: +$17.56 (+27%) info
Market Cap: $37.509B info